Halozyme Therapeutics Inc. buy Morgan Stanley
Start price
07.08.24
/
50%
€49.79
Target price
07.08.25
€58.59
Performance (%)
0.58%
Price
16:59
€50.08
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Halozyme Therapeutics Inc. is nearly unchanged. This prediction currently runs until 07.08.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Halozyme Therapeutics Inc. | 0.58% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by Morgan_Stanley for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Morgan Stanley from $59.00 to $64.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.03
26.12.23
26.12.23
€53.50
26.12.24
26.12.24
47.16%
16:59
16:59
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€40.11
10.08.23
10.08.23
€55.35
10.08.24
10.08.24
24.86%
16:59
16:59
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.50
06.03.23
06.03.23
€60.06
06.03.24
06.03.24
-10.61%
07.03.24
07.03.24